Evidence map›Paper›PMID 42220973›Full record

ReviewInternational journal of nanomedicine2026

Biological Safety Analysis of Nanoparticles: Exploring Toxicity, Mechanisms, and Safety Factors for Pharmaceuticals.

Anxian Huang, Ziying Jiang, Zhiyuan Liang, Naping Tang, Jingjing Liu, Xie-An Yu, Bing Wang, Xiaowei Wang

Abstract readReview
In one paragraph

Review in International journal of nanomedicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anxian Huang *China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China.
Ziying Jiang *China State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China.
Zhiyuan LiangNMPA Center for Innovation and Research in Regulatory Science, Shenzhen Institute for Drug Control, Shenzhen, People's Republic of China.ORCID 0009-0009-2323-6626
Naping TangChina State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China.
Jingjing LiuNMPA Center for Innovation and Research in Regulatory Science, Shenzhen Institute for Drug Control, Shenzhen, People's Republic of China.
Xie-An YuNMPA Center for Innovation and Research in Regulatory Science, Shenzhen Institute for Drug Control, Shenzhen, People's Republic of China.ORCID 0000-0003-2918-7369
Bing WangNMPA Center for Innovation and Research in Regulatory Science, Shenzhen Institute for Drug Control, Shenzhen, People's Republic of China.
Xiaowei WangChina State Institute of Pharmaceutical Industry, Shanghai, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the rapid advancement of nanotechnology, nanoparticles (NPs) have been widely applied in fields such as drug delivery, medical imaging, and disease therapy, owing to their unique physicochemical and biological properties. However, as NPs become increasingly prevalent in industrial production and daily life, the frequency and routes of human exposure have significantly increased, making the safety issues arising from their interactions with biological systems a major focus of public health concern. Methods: This review systematically retrieved relevant literature from databases including PubMed and Web of Science over the past 15 years, focusing on toxicological studies of NPs at the organ and system levels. Results: It summarizes the key mechanisms of nanotoxicity and the critical factors influencing safety evaluation. The findings indicate that NPs toxicity primarily targets the liver, kidneys, nervous system, and immune system. Oxidative stress, inflammatory responses, and DNA damage represent the major common mechanisms of nanotoxicity, while physicochemical properties such as particle size, surface charge, and protein corona formation are the core factors affecting safety. Conclusion: Based on these findings, this review analyzes the limitations of existing research in the context of the current research landscape, aiming to provide theoretical support for the safe application of NPs and to offer a reference for the establishment of a systematic nanotoxicity safety evaluation framework.

Indexed as

NanoparticlesAnimalsHumansOxidative Stressbiological safetynanoparticlessafety factorstoxicity mechanism

Identifiers

PMID42220973
PMCPMC13220827

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.